In this study, we utilize small molecule inhibitors of GSK3β or phospho-incompetent mutations that individually target the known sites of phosphorylation to determine how inhibiting these events on PAX3-FOXO1 affects ARMS tumor phenotypes. Here, KIDINS220 is linked to neoplasm.